The Bayer Group continued its positive business momentum in the third quarter of 2013 with substantial contributions from the Life Science, Healthcare and CropScience sectors.
"Healthcare registered encouraging growth, largely due to the outstanding sales performance for our new pharmaceutical products," said Bayer Management Board Chairman, Dr. Marijn Dekkers.
After currency and portfolio adjustments, reported sales of the Bayer Group grew by 6.0%. Earnings before interest and tax improved by a substantial 47.5% to EUR 1,221 million. Gross cash flow moved ahead by 35.9% to EUR 1,367 million, mainly as a result of the significant improvement in EBIT. Net cash flow fell by 13.0% to EUR 1,728 million because less working capital was released than in the prior-year quarter. Net financial debt declined from EUR 9.0 billion on June 30, 2013 to EUR 7.7 billion on Sept. 30, 2013, largely as a result of cash inflows from operating activities.
For the full report, visit BAYER INVESTOR RELATIONS
Showing posts with label earnings. Show all posts
Showing posts with label earnings. Show all posts
04 November 2013
11 October 2013
Consumer and Shareowner Value Creation is Top Priority, P&G CEO Tells Shareowners
Procter & Gamble has established consumer and shareowner value creation as its top priority, chairman, president and CEO A.G. Lafley told the company's shareowners at its annual general meeting earlier this week.
In a review of the business over the past year, Mr. Lafley said P&G had met or exceeded its key financial commitments, including organic sales growth, core earnings per share and free cash flow productivity. The company returned $12.5 billion in cash to share owners. However, he emphasized the company can do better.
Lafley stressed that the company will focus on its core businesses, which include the leading most profitable brands, categories and countries. P&G must ensure its U.S. business is strong and growing while investing in developing markets that have the largest size of prize and where P&G has the highest likelihood of winning. Resources will be allocated to businesses where value can be created and the company will exit those that cannot deliver acceptable shareowner returns.
"We have taken a hard look at what we need to do and how we need to change to perform better," said Lafley. "We're committed to do what it takes to get P&G back to balanced, consistent, reliable and sustainable growth and value creation for consumers, customers, and you, our shareholders."
In a review of the business over the past year, Mr. Lafley said P&G had met or exceeded its key financial commitments, including organic sales growth, core earnings per share and free cash flow productivity. The company returned $12.5 billion in cash to share owners. However, he emphasized the company can do better.
Lafley stressed that the company will focus on its core businesses, which include the leading most profitable brands, categories and countries. P&G must ensure its U.S. business is strong and growing while investing in developing markets that have the largest size of prize and where P&G has the highest likelihood of winning. Resources will be allocated to businesses where value can be created and the company will exit those that cannot deliver acceptable shareowner returns.
"We have taken a hard look at what we need to do and how we need to change to perform better," said Lafley. "We're committed to do what it takes to get P&G back to balanced, consistent, reliable and sustainable growth and value creation for consumers, customers, and you, our shareholders."
15 August 2013
PetSmart, Inc. to host second quarter 2013 earnings conference call
PetSmart, Inc. will release its results for the second quarter 2013 before market opens on Wednesday, August 21, 2013. Additionally, the company will host a conference call the same day beginning at 10 a.m. (EDT), to discuss the results of the quarter.
To listen to the live call:
Within the United States and Canada: (866) 219-5631
Internationally: (703) 639-1122
Conference ID #: 1621111
To access the replay:
Within the United States and Canada: (888) 266-2081
Internationally: (703) 925-2533
Conference ID #: 1621111
The announcement will be archived at www.petm.com
To listen to the live call:
Within the United States and Canada: (866) 219-5631
Internationally: (703) 639-1122
Conference ID #: 1621111
To access the replay:
Within the United States and Canada: (888) 266-2081
Internationally: (703) 925-2533
Conference ID #: 1621111
The announcement will be archived at www.petm.com
16 March 2013
VCA Antech weathers the storm
Despite reports the companion animal industry is 'recession proof', VCA Antech saw sales revenues per hospital (those open more than a year) decline for 10 consecutive quarters from 2009 to 2011, according to a research report by investment firm William Blair and Co.
An analysis of the company's financial history in the LA Times earlier this month reported that VCA's earnings plummeted to $50.7 million in 2012, it's fourth consecutive year of decline after peaking at $137 million in 2008.
"If our pets are sick, we'll spend the money," said Robert L. Antin, the company's co-founder and CEO. "If they're well and it's a bad economic time, they may say, 'we don't need to see the vet.' So the economy has hurt us, just like it's hurt everybody else."
VCA Antech has grown through a series of acquisitions, helping to boost revenue even as visits to existing hospitals fell. The pet hospital firm nearly doubled in size from 2006 to 2012.
Antin told the LA Times the company's acquisitions have left it well-postioned to thrive as the economy recovers and pet owners' discretionary income increases. Reports show a slight increase in sales per hospital (those open for more than a year) for the past six quarters.
About VCA Antech
VCA Antech owns or manages more than 600 veterinary hospitals in the US and Canada, with more than 3,000 veterinarians on staff. It also owns a network of diagnostic laboratories and sells radiography and ultrasound imaging equipment to veterinarians.
An analysis of the company's financial history in the LA Times earlier this month reported that VCA's earnings plummeted to $50.7 million in 2012, it's fourth consecutive year of decline after peaking at $137 million in 2008.
"If our pets are sick, we'll spend the money," said Robert L. Antin, the company's co-founder and CEO. "If they're well and it's a bad economic time, they may say, 'we don't need to see the vet.' So the economy has hurt us, just like it's hurt everybody else."
VCA Antech has grown through a series of acquisitions, helping to boost revenue even as visits to existing hospitals fell. The pet hospital firm nearly doubled in size from 2006 to 2012.
Antin told the LA Times the company's acquisitions have left it well-postioned to thrive as the economy recovers and pet owners' discretionary income increases. Reports show a slight increase in sales per hospital (those open for more than a year) for the past six quarters.
About VCA Antech
VCA Antech owns or manages more than 600 veterinary hospitals in the US and Canada, with more than 3,000 veterinarians on staff. It also owns a network of diagnostic laboratories and sells radiography and ultrasound imaging equipment to veterinarians.
01 March 2011
PetSmart Reports Financial Results
For the quarter, earnings per share were up 26% to $0.77. Comparable
store sales, or sales in stores open at least a year, grew 6.3%,
benefitting from comparable transactions growth of 4.4%. Total sales for
the quarter were up 8.1% to $1.5 billion, partially impacted by $4
million in favorable foreign currency fluctuations. Services sales,
which are included in total sales, grew 7.2% to $152 million.
For the year, the company delivered earnings per share of $2.01, up 26%
compared to $1.59 last year. Comparable store sales grew 4.8%,
benefitting from comparable transactions growth of 2.1%. Total sales for
the year were $5.7 billion, up 6.7%, including a favorable impact from
foreign currency fluctuations of $25 million, and services sales grew
7.5% to $619 million.
During the year, the company generated $458 million in operating cash
flow and spent $125 million in capital expenditures. In addition, the
company repurchased $263 million of PetSmart stock during 2010, with
$100 million repurchased during the fourth quarter. The company also
distributed $53 million in dividends during 2010, ending the year with
$353 million in cash, cash equivalents and restricted cash and zero
borrowings on its credit facility.
"We are pleased to report that we exceeded our goals for 2010 and
delivered record results," said Bob Moran, Chief Executive Officer and
President. "Our third consecutive quarter of accelerating comparable
transactions growth as well as a strong holiday performance led to
better-than-expected results for the quarter."
PetSmart management has scheduled a teleconference for 4:30 p.m. EST on
March 2, 2011, to discuss results for the fourth quarter and fiscal year
2010. This teleconference will be webcast live for all investors at http://www.petm.com/ or http://www.streetevents.com/
Subscribe to:
Posts (Atom)